Neuried, Germany

Katharina Aulinger Fuchs


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Katharina Aulinger Fuchs: Pioneering Advances in Protozoal Disease Treatment**

Introduction

Katharina Aulinger Fuchs, a talented inventor based in Neuried, Germany, has made significant contributions to the field of medicinal chemistry. With a strong focus on developing effective compounds for treating protozoal diseases, she has exemplified the innovative spirit that drives research and development in the health sector.

Latest Patents

Katharina holds a notable patent for her invention of new diphenylurea compounds, specifically aimed at the treatment of protozoal diseases. The patent details a unique formula that showcases her creativity and expertise in medicinal chemistry, further establishing her influence within the scientific community.

Career Highlights

Currently, Katharina Aulinger Fuchs is associated with 4SC AG, a company recognized for its commitment to innovative drug research and development. Her work there has allowed her to collaborate with leading experts in the field and contribute to advancing therapeutic solutions.

Collaborations

Throughout her career, Katharina has collaborated with notable colleagues, including Andrea Aschenbrenner and Matthias Dormeyer. These partnerships have facilitated the exchange of ideas and knowledge, enhancing the inventive process and propelling the development of groundbreaking treatments.

Conclusion

In conclusion, Katharina Aulinger Fuchs stands out as an inspiring inventor whose work in developing compounds for the treatment of protozoal diseases highlights the importance of innovation in addressing public health challenges. Her ongoing contributions through partnerships and research at 4SC AG strengthen the pursuit of effective medical solutions, making her a valuable asset in the field of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…